David Baxley Spetzler insider trades
Open-market stock purchases and sales by David Baxley Spetzler, President at Caris Life Sciences, Inc, from SEC Form 4 filings since Mar 3, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +34%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 4, 2026 | CAI Caris Life Sciences, Inc | Sold | $3M |
| Sep 4, 2026 | CAI Caris Life Sciences, Inc | Bought (not open market) | — |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc | Sold | $9.7M |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc | Sold | $2.1M |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc | Bought (not open market) | — |
| May 15, 2026 | CAI Caris Life Sciences, Inc | Sold (not open market) | $211K |
| Mar 6, 2026 | CAI Caris Life Sciences, Inc | Bought (not open market) | — |
| Nov 7, 2025 | CAI Caris Life Sciences, Inc | Bought | $9.5K |
Companies traded
- CAI Caris Life Sciences, Inc: 1 buy, 3 sales, last Sep 4, 2026
Get free alerts when David Baxley Spetzler files a new trade →